eli lilly phase 3 trial retatrutide Today, we shared new data from the latest study of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more Today, we shared new data

So I desperately started throwing money at any "solution" I could find $400 on dermatologist visits where I was basically told to just "just wait it out" $250 on biotin supplements and hair vitamins that made no difference $180 on expensive shampoos promising to "stimulate growth" $300 on a laser cap that did absolutely nothing Each failure made me more desperate and more suspicious

Side effects were most likely to show up when starting the medication or increasing the dose , which is why the step-up dosing schedule matters

Not losing weight on GLP-1s: Common pitfalls and fixes

Availability of data and materials Not applicable

A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1

70-80% weight regain within 12-18 months is the norm, not the exception